Walgreens Adopts New Measures To Fight Against Coronavirus
Zacks Investment Research | Mar 15, 2020 09:44PM ET
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has taken a number of measures to help patients fight against Coronavirus. The most notable initiative, like peer CVS Health (NYSE:CVS), is that the company has decided to waive off prescription drug home delivery charges during the time of pandemic. Further, there will be no delivery charges on any purchase on Walgreens.com.
While doing so, in order to ensure proper patent accessibility to the medication, the company has started to collaborate with health plan partners, physicians and state officials for seamless execution of services like 90-day refills and early refill authorizations.
Further, the company stated that 24-hours online medical services like Walgreens Pharmacy Chat, available through the Walgreens mobile app and pharmacy drive-thru as alternative ways to access medications, can be well utilized now.
Notably, Find Care service can effortlessly connect customers to a large number of telehealth options available through Walgreens app. Find Care can also help patients to access a range of locally-provided health care services.
The company has also put purchase limit on certain items that customers are stockpiling now. This inventory accumulation by the company is aimed at wider distribution of available products.
In this regard, the company recently collaborated with industry partners as well as healthcare administrators to provide access to government-run COVID-19 testing facilities. It will provide temporary space at select locations, outside of the stores where non-Walgreens health personnel will administer COVID-19 testing. This will be performed in collaboration with the Administration, Centers for Disease Control and Prevention (CDC), and Centers for Medicare and Medicaid Services (CMS).
Going by Forbes, apart from Walgreens Boots, Walmart (NYSE:WMT), Target (NYSE:TGT), and CVS Health will play a central role in the U.S. government's plan to make COVID-19 tests accessible across the country as the outbreak of the illness worsens.
Meanwhile, shares of Walgreens Boots rallied 12.6% on Friday, following its series of initiatives related to the coronavirus-led damage control. On proper execution of the company’s recent measures to help stay-at-home initiatives against the coronavirus-led backdrop, we believe it to register greater customer adoption in this period.
Share Price Performance
Over the past three months, the stock has lost 19% compared with the Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.